Showing 19,461 - 19,480 results of 104,446 for search '(( a step decrease ) OR ( 5 ((point decrease) OR (((mean decrease) OR (a decrease)))) ))', query time: 1.74s Refine Results
  1. 19461

    Reduction Pathway of End-On Terminally Coordinated Dinitrogen. IV. Geometric, Electronic, and Vibrational Structure of a W(IV) Dialkylhydrazido Complex and Its Two-Electron-Reduced... by Kay H. Horn (2684512)

    Published 2005
    “…The molybdenum and tungsten dialkylhydrazido complexes [M(dppe)<sub>2</sub>(NNC<sub>5</sub>H<sub>10</sub>)]<sup>2+</sup> (M = Mo, W; compounds <b>A</b><sup>Mo</sup> and <b>A</b><sup>W</sup>) and their two-electron-reduced counterparts [M(dppe)<sub>2</sub>(NNC<sub>5</sub>H<sub>10</sub>)] (compounds <b>B</b><sup>Mo</sup> and <b>B</b><sup>W</sup>) are characterized structurally and spectroscopically. …”
  2. 19462

    Concept of heat-dissipation time as a fundamental constraint to the realised travel speeds of animals. by Alexander Dyer (15314519)

    Published 2023
    “…An increase in heat-dissipation time, therefore, corresponds to a reduced stride frequency and a net decrease in the realised travel speed. …”
  3. 19463
  4. 19464

    Detection of Proteome Changes in Human Colon Cancer Induced by Cell Surface Binding of Growth-Inhibitory Human Galectin‑4 Using Quantitative SILAC-Based Proteomics by Malwina Michalak (505581)

    Published 2016
    “…The strongest induction was found for CALB2 (calretinin; ∼24-fold), TGM2 (protein-glutamine γ-glutamyltransferase 2; ∼11-fold), S100A3 (∼10-fold), and GSN (gelsolin; 9.5-fold), and the most pronounced decreases were seen for CDKN2A (tumor suppressor ARF; ∼6-fold), EPCAM (epithelial cell adhesion molecule; ∼6-fold), UBE2C (ubiquitin-conjugating enzyme E2 C; ∼5-fold), KIF2C (kinesin-like protein KIF2C; 5-fold), and LMNB1 (lamin-B1; ∼5-fold). …”
  5. 19465

    Detection of Proteome Changes in Human Colon Cancer Induced by Cell Surface Binding of Growth-Inhibitory Human Galectin‑4 Using Quantitative SILAC-Based Proteomics by Malwina Michalak (505581)

    Published 2016
    “…The strongest induction was found for CALB2 (calretinin; ∼24-fold), TGM2 (protein-glutamine γ-glutamyltransferase 2; ∼11-fold), S100A3 (∼10-fold), and GSN (gelsolin; 9.5-fold), and the most pronounced decreases were seen for CDKN2A (tumor suppressor ARF; ∼6-fold), EPCAM (epithelial cell adhesion molecule; ∼6-fold), UBE2C (ubiquitin-conjugating enzyme E2 C; ∼5-fold), KIF2C (kinesin-like protein KIF2C; 5-fold), and LMNB1 (lamin-B1; ∼5-fold). …”
  6. 19466
  7. 19467
  8. 19468
  9. 19469
  10. 19470
  11. 19471

    Mean and two standard deviations from LNA versus stochastic simulations for Lotka-Volterra model. by Christoph Zimmer (3095667)

    Published 2016
    “…The lower row shows p-values of a Kolmogorov-Smirnov test for each time point whether the 100 stochastic simulations follow a normal distribution with mean and variance from a LNA. …”
  12. 19472
  13. 19473

    Ferroelectricity and a 1/3-Magnetization Plateau in the Polar Magnet LiFeV<sub>2</sub>O<sub>7</sub> with Fe<sup>3+</sup> Ions in a Twisted Diamond Chain by Ravi Shankar P N (9740817)

    Published 2025
    “…LiFeV<sub>2</sub>O<sub>7</sub> crystallizes in a polar monoclinic <i>Cc</i> structure, where Fe<sup>3+</sup> (<i>S</i> = 5/2) ions form diamond chains along the [101] direction, each surrounded by four neighboring chains. …”
  14. 19474
  15. 19475
  16. 19476

    AP firing rate is decreased while AHP is increased in SO of CA2/3 fast–spiking interneurons of PICRO-treated rats in the presence of kainic acid (KA). by Barbara Gisabella (330774)

    Published 2013
    “…<b>F</b>, Plot of instantaneous firing frequency versus time for spikes elicited by single current steps during the first 500 ms of a 1s current pulse in slices from PICRO rats with or without KA in the external solution. * p = <0.05 or ***p<0.001. …”
  17. 19477

    Data Sheet 1_Impact of the SARS-COV-2 pandemic on access to health services in Angola: a focus on diagnosis and treatment services for tuberculosis.docx by Susanna Caminada (16789893)

    Published 2025
    “…</p>Results<p>There was a significant decline in access to TB services during the pandemic, with a substantial decrease in reported cases (−15.5% in 2020; −18.3% in 2021) and treatment rate (from 86% in 2019 to 68% in 2020), an increase in multidrug-resistant-TB (from 0.2% in 2018 to 2.1% in 2022) and TB/HIV co-infections (from 6% in 2018 to 8.8% in 2021). …”
  18. 19478
  19. 19479
  20. 19480